1/ Beware the #IdesOfMarch, #medtwitter, and happy Sunday to one and all!
Today, we’d like to present you with a little #FoodForThought, and we’d love to hear your reactions. Please reply to this thread with your thoughts and let’s get this conversation going!
Today, we’d like to present you with a little #FoodForThought, and we’d love to hear your reactions. Please reply to this thread with your thoughts and let’s get this conversation going!
2/ The past 3 years have seen the approval of the first treatments to address the root pathophysiology of #sicklecelldisease since the introduction of hydroxyurea in 1998. This is a huge leap in the management of a painful and burdensome illness.
3/ However, experts doubt that they will be realistic options for most patients due to prohibitive cost.
4/ This is a growing issue in the treatment of many diseases like sickle cell: advances in targeted biotechnology make them more treatable in theory, but high costs still stand in the way of widespread use.
5/ #FoodForThought: What challenges are there to offering, or not offering, expensive treatments for illnesses with otherwise limited treatment options? Is it possible to set an acceptable price tag, or narrow the candidates to whom it's provided? And who should foot the bill?
6/ Learn more about these questions and the novel drugs themselves at nature.com
/fin
/fin
Loading suggestions...